Evidence mapPaperPMID 39098994Full record

ArticleJournal of cellular and molecular medicine2024

Integrating single-cell transcriptomics and machine learning to predict breast cancer prognosis: A study based on natural killer cell-related genes.

Juanjuan Mao, Ling-Lin Liu, Qian Shen, Mengyan Cen

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Single-Cell RNA-Sequencing: Opening New Horizons for Breast Cancer Research.International journal of molecular sciences · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juanjuan MaoDepartment of Thyroid and Breast Surgery, Ningbo Hospital of TCM Affiliated to Zhejiang Chinese Medicine University, Ningbo City, Zhejiang Province, China.ORCID 0009-0000-4651-278X
Ling-Lin LiuDepartment of Thyroid and Breast Surgery, Ningbo Hospital of TCM Affiliated to Zhejiang Chinese Medicine University, Ningbo City, Zhejiang Province, China.
Qian ShenDepartment of Thyroid and Breast Surgery, Ningbo Hospital of TCM Affiliated to Zhejiang Chinese Medicine University, Ningbo City, Zhejiang Province, China.
Mengyan CenDepartment of Thyroid and Breast Surgery, Ningbo Hospital of TCM Affiliated to Zhejiang Chinese Medicine University, Ningbo City, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the most commonly diagnosed cancer in women globally. Natural killer (NK) cells play a vital role in tumour immunosurveillance. This study aimed to establish a prognostic model using NK cell-related genes (NKRGs) by integrating single-cell transcriptomic data with machine learning. We identified 44 significantly expressed NKRGs involved in cytokine and T cell-related functions. Using 101 machine learning algorithms, the Lasso + RSF model showed the highest predictive accuracy with nine key NKRGs. We explored cell-to-cell communication using CellChat, assessed immune-related pathways and tumour microenvironment with gene set variation analysis and ssGSEA, and observed immune components by HE staining. Additionally, drug activity predictions identified potential therapies, and gene expression validation through immunohistochemistry and RNA-seq confirmed the clinical applicability of NKRGs. The nomogram showed high concordance between predicted and actual survival, linking higher tumour purity and risk scores to a reduced immune score. This NKRG-based model offers a novel approach for risk assessment and personalized treatment in BC, enhancing the potential of precision medicine.

Indexed as

Breast NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticKiller Cells, NaturalMachine LearningSingle-Cell AnalysisTranscriptomeTumor MicroenvironmentBiomarkers, TumorFemaleHumansNomogramsPrognosisBiomarkers, Tumorbreast cancerimmune microenvironmentmachine learningenatural killer cellsprecision medicine

Identifiers

PMID39098994
PMCPMC11298315

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.